Circulatory metastin/kisspeptin-1 in polycystic ovary syndrome: a systematic review and meta-analysis with diagnostic test accuracy.
Varikasuvu. Seshadri Reddy SR; Prasad. V Satya VS; Vamshika. V C VC; Satyanarayana. M V MV; Panga. Jaipal Reddy JR
Key Findings
- Women with PCOS have significantly higher circulating kisspeptin‑1 levels (SMD = 0.47).
- Kisspeptin‑1 positively correlates with AMH, testosterone, and dehydroepiandrosterone (DHEA).
- Diagnostic tests using kisspeptin‑1 show a pooled diagnostic odds ratio of 13.71 and an AUC of 0.835, indicating good accuracy for detecting PCOS.
Practical Outcomes
- For biohackers, this research mainly confirms that kisspeptin‑1 is a promising biomarker for PCOS, but it doesn’t provide dosing or treatment guidance. It may be useful for those tracking hormonal health or considering future diagnostic tools, yet there’s no immediate protocol to apply.
Summary
People with polycystic ovary syndrome (PCOS) tend to have higher levels of the hormone kisspeptin-1 in their blood. The study found that kisspeptin-1 levels are linked to other PCOS‑related markers like AMH, testosterone, and DHEA, and that measuring kisspeptin‑1 could help identify PCOS with fairly good accuracy.
Abstract
A close association between Kisspeptin-1 (KISS-1) and reproductive physiology has been reported, but the results on circulatory KISS-1 are ambiguous in patients with polycystic ovary syndrome (PCOS). A systematic review and meta-analysis were conducted to evaluate the association between KISS-1 and PCOS, and to test its diagnostic test accuracy (DTA) through DTA meta-analysis. Relevant studies were identified by searching PubMed and other databases in addition to manual searching of cross-references. Random-effects model was used to obtain standardized mean differences (SMD), pooled correlation coefficients and summary of DTA. Meta-regression and sub-group analyses were conducted to explore heterogeneity. The presence of publication bias was tested using funnel plot analysis. This meta-analysis finally included 12 studies. Compared with controls, women with PCOS showed significantly increased circulatory KISS-1 levels (SMD = 0.47; P = 0.002). Meta-analysis of correlations showed positive associations between KISS-1 and anti-Müllerian hormone (AMH) (P = 0.03), testosterone (P < 0.001) and dehydroepiandrosterone (P = 0.004). The pooled diagnostic odds ratio and area under curve were 13.71 and 0.835, respectively. A one-study leave-out sensitivity analysis indicated that no single study had a significant influence on the overall outcome, suggesting the robustness of this meta-analysis. This meta-analysis showed significantly increased KISS-1 level in PCOS, and its association with AMH reflects its role in reproductive physiology. In our DTA meta-analysis, KISS-1 showed good accuracy for PCOS detection. Further large-scale studies are required to establish its validity.
Study Information
pubmed
2019
2019-05-02T00:00:00.000Z
10.1016/j.rbmo.2019.04.018